TECH - Tempus AI Has Massive Market Opportunity For This Healthcare Technology Bullish Analyst Says | Benzinga
William Blair initiated coverage on Tempus AI, Inc (NASDAQ:TEM), citing the company’s ‘differentiated approach and business model.’
Tempus AI is a healthcare technology company that utilizes artificial intelligence technology to collect and analyze molecular, clinical, and genomic data.
It collects clinical and genomic databases from academic medical centers and community-based hospitals.
Related: Tempus Could Gain Share In AI Health Care Market Poised To Grow By Over 30%.
In June, the company launched an IPO priced at $37 per share via selling 11.1 million shares, with gross proceeds of around $410.7 ...